28th Jun 2016 09:26
LONDON (Alliance News) - Eden Research PLC on Tuesday reiterated that its outlook is "better than it has been at any point in the past", as it continued to make progress with its agrochemical fungicide product 3AEY.
3AEY has got EU approval in Malta, Italy, Bulgaria, Kenya, Greece and Spain. Sales have been made in Italy and Spain where its partner is manufacturing the product itself, and approval in France is expected in 2016.
"Eden has a well-balanced portfolio of products, projects and opportunities at differing levels of risk of commercial success, the first of which is now bearing fruit, with a strong pipeline behind it. All part of the process of Eden becoming a truly commercial entity, having shifted from a purely development phase," said Chairman Top Lupton in a statement ahead of the company's annual general meeting.
Shares in Eden Research were trading flat at 8.25 pence Tuesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Eden